05:41 03-09-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
India's Sun Pharma buys Ranbaxy for $4 billion

Bishkek (AKIpress) - Sun_Pharma India's Sun Pharmaceutical Industries is buying troubled generic drugmaker Ranbaxy Laboratories in a $4 billion all-stock transaction, Miami Herald reported today.

The combined company will be India's biggest pharmaceutical firm, with annual revenue estimated at $4.2 billion.

Shares of Sun Pharma rose 1.7 percent. Ranbaxy's shares were down 4.8 percent in trading on the Bombay Stock Exchange.

Ranbaxy is the leading drugmaker in India's $26 billion generic pharmaceutical industry, but it has faced penalties from U.S. regulators for years. The U.S. has banned imports of drugs from two of its factories because of concerns about quality control.

The acquisition will allow Sun Pharma to tap into Ranbaxy's strong global presence and manufacturing capabilities. The combined company will have 47 factories across five continents and operations in 65 countries.

Ranbaxy has annual revenue of about $2 billion.


Twitterfacebookprint
15:31 07.04.2014
LATEST NEWS
17:53 Landmark project upgrades Tajikistan’s Qairokkum hydropower plant17:46 Visit of Chinese President Xi Jinping in Dushanbe to have historical character – China's Ambassador to Tajikistan17:41 Kazakhstani Ambassador to Romania, Germany, Cambodia and Laos appointed17:36 Bastian Schweinsteiger announced as Germany's new captain17:28 Tajikistan reduces projections of raw cotton yield by almost 33%17:23 China accuses British MPs of Hong Kong 'interference'17:22 Inflation growth projected to continue until end of 2014 in Kyrgyzstan17:12 Ambassador of Kazakhstan to Saudi Arabia presents his credentials to King of Saudi Arabia17:11 Navoi Mining and Metallurgy Complex to supply 2,000 metric tons of uranium ore to India17:07 National Bank suggests revision of Banking Code in connection with prospective Customs Union accession17:01 Foreign Minister Abdyldayev, UN Resident Coordinator discuss cooperation issues17:00 Emergency Situations Ministry set to warn population about earthquakes 15 seconds before their beginning17:00 Kazakhstani Government to develop arbitration law, Nazarbayev orders16:48 Introduction of unified information management system in Kyrgyzstan to reduce number of victims from disasters by 10% – Emergency Ministry16:46 Flour shortage not observed in Kyrgyzstan, Kazakhstan still supplies - Antitrust Regulation Agency16:42 Tajik authorities not ready to hold transparent and free elections – Islamic Party's leader16:27 IDB to provide $100 million for construction of modern rural housing in Uzbekistan16:13 Nazarbayev orders Government to adopt Kazakhstan Anti-Corruption Strategy by end 201416:11 Border checkpoints of Kyrgyzstan provided with thermographic cameras to prevent importation of Ebola virus16:10 Turkmenistan's President, Azerbaijan's Deputy Foreign Minister discuss development of bilateral relations
Astana
+17° C
Ashgabat
+33° C
Bishkek
+29° C
Dushanbe
+27° C
Tashkent
+32° C
exchange rates
 
69.59
52.95
8.62
1.42
238.73
182.00
29.60
4.87
6.49
4.97
0.81
0.13
3112.24
2351.84
382.77
63.06
3.74
2.85
0.46
0.08

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75